Why Loblaw Is a Safe Bet Today

Loblaw Companies Ltd is one of the best defensive picks for capital preservation in these volatile times.

| More on:
Supermarket aisle with empty green shopping cart

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s premium investing services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn moresdf

Loblaw Companies (TSX:L) has emerged as one of the few coronavirus-resilient stocks in the market today. This leading multi-category Canadian retailer managed to remain mostly unscathed from the broad market-wide sell-off in late February and March 2020. Pandemic or not, people require food, household products, and medicine. Loblaw has benefitted from the inelastic demand for essential products.

Changing consumer behaviour is a major tailwind

Although the global economy is now opening up, people still remain apprehensive about mingling with strangers. This will be the new norm until an effective COVID-19 vaccine becomes widely available. People are limiting visits to restaurants and malls to avoid contracting infection. People may also prefer multi-category retailers over specialty retailers, as they look to make larger purchases in fewer shopping visits. Loblaw will most likely benefit from these changes in 2020.

Loblaw’s broad retail footprint is also pivotal to faster and more cost-effective functioning in both click-and-collect and home-delivery market segments. Click-and-collect continues to account for a major portion of its online business. The company is also working towards reducing average wait times in the home-delivery segment.

A more permanent change in consumer behaviour seems to be on the horizon. As the global economy increasingly adopts flexible working options, people may opt to cook from scratch. With Loblaw currently selling food and medicines to over 90% Canadians, the company will be an obvious long-term beneficiary of this change.

Loblaw’s scale and broad supplier network can help it control product prices. This becomes quintessential, especially in difficult economic environments.

Loblaw’s dividend and share-repurchase strategy

Loblaw pays an annual dividend of $1.26 per share, which now translates into a dividend yield of 1.96%. The company has not announced a dividend raise in first quarter but plans to do so in fiscal 2020. Loblaw also repurchased 2.8 million common shares for $188 million in the first quarter.

These risks cannot be ignored

Although Loblaw has posted healthy revenue and earnings growth in the first quarter, there are definitely some challenges that the company will have to overcome in the remaining part of fiscal 2020.

Reduced consumer discretionary spending is affecting the company’s top line. Increasing unemployment has forced customers to rein in discretionary spending, a trend that will most likely continue, even after the lockdown restrictions are lifted. However, the company may manage to partly offset the impact. In recessionary times, people are more likely to trade down brands of discretionary items. The company’s discount division may benefit from this trend since its product mix is more geared towards general merchandise, apparel, and beauty products.

The second quarter of 2020 may also not be as rosy for Loblaw, even on the margin front. The shift of its product mix towards low-margin pantry items and away from higher-margin general merchandise items will continue to pressure the bottom line. An additional $90 million monthly investment in COVID-19-related expenses is taking a toll on the company’s margins. The increased volatility in shopping behaviours in these uncertain times has forced the company to withdraw its 2020 outlook.

Bottom line

Loblaw is definitely not a growth stock and will most likely not make you a millionaire. It is also not the best of income-generating stocks in the market. However, it is definitely one of the best defensive stocks for capital preservation in today’s volatile markets.

This article represents the opinion of the writer, who may disagree with the “official” recommendation position of a Motley Fool premium service or advisor. We’re Motley! Questioning an investing thesis — even one of our own — helps us all think critically about investing and make decisions that help us become smarter, happier, and richer, so we sometimes publish articles that may not be in line with recommendations, rankings or other content.

Fool contributor Manali Bhade has no position in any of the stocks mentioned.

More on Coronavirus

little girl in pilot costume playing and dreaming of flying over the sky
Coronavirus

Air Canada Stock: How High Could it go?

AC stock is up 29% in the last six months alone, so should we expect more great things? Or is…

Read more »

eat food
Coronavirus

Goodfood Stock Doubles Within Days: Time to Buy?

Goodfood (TSX:FOOD) stock has surged 125% in the last few weeks, so what happened, and should investors hop back on…

Read more »

stock data
Tech Stocks

If I Could Only Buy 1 Stock Before 2023, This Would Be It

This stock is the one company that really doesn't deserve its ultra-low share price, so I'll definitely pick it up…

Read more »

Aircraft Mechanic checking jet engine of the airplane
Coronavirus

Air Canada Stock Fell 5% in November: Is it a Buy Today?

Air Canada (TSX:AC) stock saw remarkable improvements during its last quarter but still dropped 5% with more recession hints. So,…

Read more »

Airport and plane
Coronavirus

Is Air Canada Stock a Buy Today?

Airlines are on the rebound. Does Air Canada stock deserve to be on your buy list?

Read more »

A patient takes medicine out of a daily pill box.
Coronavirus

Retirees: 2 Healthcare Stocks That Could Help Set You up for Life

Healthcare stocks offer an incredible opportunity for growth for those investors who look to the right stocks, such as these…

Read more »

sad concerned deep in thought
Coronavirus

Here’s Why I Just Bought WELL Health Stock

WELL Health stock (TSX:WELL) may be a healthcare stock and a tech stock, but don't let that keep you from…

Read more »

healthcare pharma
Coronavirus

WELL Stock: The Safe Stock Investors Can’t Afford to Ignore

WELL stock (TSX:WELL) fell 68% from peak to trough, and yet there's no good reason as to why. So now…

Read more »